We describe the clinical and laboratory features of an unusual case wi
th Sezary cell-like leukemia. Clinical manifestations were: anemia (Hb
9.4 g/dl), severe thrombocytopenia (5 x 10(9)/l), lymphocytosis (43 x
10(9)/l) and splenomegaly. There was no lymphadenopathy, hepatomegaly
or skin lesions. Bone marrow trephine showed diffuse infiltration by
atypical lymphoid cells. By ultrastructural analysis the cells were sm
all to medium-size lymphocytes with nuclear features identical to Seza
ry cells. immunophenotyping showed that most peripheral blood mononucl
ear cells were negative with B lymphoid, myeloid, and stem cell-associ
ated markers and were also negative with most T lymphoid markers (CD2,
CD4, membrane/cytoplasmic CD3, CD5 and CD8). However, they were posit
ive with CD38 (70%), CD7 (25%) and TIA-2 (25%). Molecular analysis sho
wed a clonal rearrangement of the TCR beta and gamma chain genes. The
patient was initially treated with vincristine, doxorubicin and aspara
ginase and then with six cycles of CHOP, achieving a complete remissio
n and remaining free of disease 22 months from diagnosis. Aberrant imm
unophenotypes are not frequent in primary T cell leukemias. This is th
e first case of a rare type of T cell neoplasm, Sezary cell-like leuke
mia, in which cells lacked most of the T cell-associated antigens.